These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 9463632)

  • 1. Protection against myocardial ischemia and reperfusion injury by 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase.
    Zingarelli B; Cuzzocrea S; Zsengellér Z; Salzman AL; Szabó C
    Cardiovasc Res; 1997 Nov; 36(2):205-15. PubMed ID: 9463632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myocardial ischemic preconditioning in rodents is dependent on poly (ADP-ribose) synthetase.
    Liaudet L; Yang Z; Al-Affar EB; Szabó C
    Mol Med; 2001 Jun; 7(6):406-17. PubMed ID: 11474134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beneficial effects of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase in a rat model of splanchnic artery occlusion and reperfusion.
    Cuzzocrea S; Zingarelli B; Costantino G; Szabó A; Salzman AL; Caputi AP; Szabó C
    Br J Pharmacol; 1997 Jul; 121(6):1065-74. PubMed ID: 9249240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitors of poly (ADP-ribose) polymerase ameliorate myocardial reperfusion injury by modulation of activator protein-1 and neutrophil infiltration.
    Kaplan J; O'Connor M; Hake PW; Zingarelli B
    Shock; 2005 Mar; 23(3):233-8. PubMed ID: 15718920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of myocardial reperfusion injury by an inhibitor of poly (ADP-ribose) synthetase in the pig.
    Bowes J; Ruetten H; Martorana PA; Stockhausen H; Thiemermann C
    Eur J Pharmacol; 1998 Oct; 359(2-3):143-50. PubMed ID: 9832385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of myocardial reperfusion injury by poly(ADP-ribose) synthetase inhibitor, 3-aminobenzamide, in cardioplegic solution: in vitro study of isolated rat heart model.
    Yamazaki K; Miwa S; Ueda K; Tanaka S; Toyokuni S; Unimonh O; Nishimura K; Komeda M
    Eur J Cardiothorac Surg; 2004 Aug; 26(2):270-5. PubMed ID: 15296882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of poly (ADP-ribose) polymerase activation by 3-aminobenzamide in a rat model of myocardial infarction: long-term morphological and functional consequences.
    Liaudet L; Szabó E ; Timashpolsky L; Virág L; Cziráki A; Szabó C
    Br J Pharmacol; 2001 Aug; 133(8):1424-30. PubMed ID: 11498530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased poly(ADP-ribosyl)ation in peripheral leukocytes and the reperfused myocardium tissue of rats with ischemia/reperfusion injury: prevention by 3-aminobenzamide treatment.
    Zhang LQ; Qi GX; Jiang DM; Tian W; Zou JL
    Shock; 2012 May; 37(5):492-500. PubMed ID: 22266967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitors of poly (ADP-ribose) synthetase protect rat cardiomyocytes against oxidant stress.
    Bowes J; McDonald MC; Piper J; Thiemermann C
    Cardiovasc Res; 1999 Jan; 41(1):126-34. PubMed ID: 10325960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beneficial effects of poly (ADP-ribose) polymerase inhibition against the reperfusion injury in heart transplantation.
    Fiorillo C; Ponziani V; Giannini L; Cecchi C; Celli A; Nediani C; Perna AM; Liguori P; Nassi N; Formigli L; Tani A; Nassi P
    Free Radic Res; 2003 Mar; 37(3):331-9. PubMed ID: 12688429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection by inhibition of poly (ADP-ribose) synthetase against oxidant injury in cardiac myoblasts In vitro.
    Gilad E; Zingarelli B; Salzman AL; Szabó C
    J Mol Cell Cardiol; 1997 Sep; 29(9):2585-97. PubMed ID: 9299380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poly (ADP-ribose) synthetase mediates intestinal mucosal barrier dysfunction after mesenteric ischemia.
    Liaudet L; Szabó A; Soriano FG; Zingarelli B; Szabó C; Salzman AL
    Shock; 2000 Aug; 14(2):134-41. PubMed ID: 10947156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of peroxynitrite and activation of poly (ADP-ribose) synthase in the vascular failure induced by zymosan-activated plasma.
    Cuzzocrea S; Zingarelli B; O'Connor M; Salzman AL; Caputi AP; Szabó C
    Br J Pharmacol; 1997 Oct; 122(3):493-503. PubMed ID: 9351506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous inhibition of poly(ADP-ribose) polymerase does not reduce reperfusion injury in isolated rat heart.
    Nishizawa K; Yanagida S; Yamagishi T; Takayama E; Bessho M; Kusuhara M; Adachi T; Ohsuzu F
    J Cardiovasc Pharmacol; 2013 Jul; 62(1):99-105. PubMed ID: 23846805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does the activation of poly (ADP-ribose) synthetase mediate tissue injury in the sepsis induced by cecal ligation and puncture?
    Baechtold F; Scott JA; Markert M; Mehta S; McCormack DG; Anglada F; Galaud D; Vaglio M; Waeber B; Feihl F
    Shock; 2001 Aug; 16(2):137-42. PubMed ID: 11508866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel phenanthridinone inhibitors of poly (adenosine 5'-diphosphate-ribose) synthetase: potent cytoprotective and antishock agents.
    Jagtap P; Soriano FG; Virág L; Liaudet L; Mabley J; Szabó E; Haskó G; Marton A; Lorigados CB; Gallyas F; Sümegi B; Hoyt DG; Baloglu E; VanDuzer J; Salzman AL; Southan GJ; Szabó C
    Crit Care Med; 2002 May; 30(5):1071-82. PubMed ID: 12006805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitors of poly (ADP-ribose) synthetase reduce renal ischemia-reperfusion injury in the anesthetized rat in vivo.
    Chatterjee PK; Zacharowski K; Cuzzocrea S; Otto M; Thiemermann C
    FASEB J; 2000 Apr; 14(5):641-51. PubMed ID: 10744621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of the activity of poly(ADP ribose) synthetase reduces ischemia-reperfusion injury in the heart and skeletal muscle.
    Thiemermann C; Bowes J; Myint FP; Vane JR
    Proc Natl Acad Sci U S A; 1997 Jan; 94(2):679-83. PubMed ID: 9012844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of tight junction derangement in the endothelial dysfunction elicited by exogenous and endogenous peroxynitrite and poly(ADP-ribose) synthetase.
    Mazzon E; De Sarro A; Caputi AP; Cuzzocrea S
    Shock; 2002 Nov; 18(5):434-9. PubMed ID: 12412622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders.
    Henning RJ; Bourgeois M; Harbison RD
    Cardiovasc Toxicol; 2018 Dec; 18(6):493-506. PubMed ID: 29968072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.